A simple blood test helps doctors recognize treatment resistance and recommend alternatives sooner.
Patients can now know whether they have treatment-resistant prostate cancer from a simple blood test—giving clinicians additional time to administer alternative therapies. The promising finding is a result of a new study co-authored by Vancouver Coastal Health Research Institute (VCHRI) researcher Dr. Alexander Wyatt.
